Valuation and Qualifying Accounts

12 Months Ended

Sep. 30, 2022

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

Valuation and Qualifying Accounts

Meridian Bioscience, Inc.

and Subsidiaries

Valuation and Qualifying Accounts

(Dollars in thousands)

Years Ended September 30, 2022, 2021 and 2020

Description	Balance at Beginning of Period		Charged to Costs and Expenses		Deductions			Other (a)			Balance at End of Period
Year Ended September 30, 2022:
Allowance for doubtful accounts	$	1,078	$	946	$	(662	)	$	(37	)	$	1,325
Inventory realizability reserves		4,997		5,121		(3,882	)		(104	)		6,132
Valuation allowances – deferred taxes		1,624		666		(760	)		(103	)		1,427
Year Ended September 30, 2021:
Allowance for doubtful accounts	$	513	$	583	$	(34	)	$	16		$	1,078
Inventory realizability reserves		3,629		2,703		(1,297	)		(38	)		4,997
Valuation allowances – deferred taxes		895		729		—			—			1,624
Year Ended September 30, 2020:
Allowance for doubtful accounts	$	537	$	34	$	(75	)	$	17		$	513
Inventory realizability reserves		2,441		1,775		(564	)		(23	)		3,629
Valuation allowances – deferred taxes		666		335		(106	)		—			895

(a) Balances reflect the effects of currency translation.